Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 251-646-7 | CAS number: 33703-08-1
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Basic toxicokinetics
Administrative data
- Endpoint:
- basic toxicokinetics
- Type of information:
- read-across from supporting substance (structural analogue or surrogate)
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 984
- Report date:
- 1984
Materials and methods
- Objective of study:
- absorption
- distribution
- excretion
- metabolism
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 417 (Toxicokinetics)
- Deviations:
- yes
- Remarks:
- urine and fecal excretion was not measured
- Principles of method if other than guideline:
- Yes, see description of method below.
- GLP compliance:
- yes (incl. QA statement)
- Remarks:
- Midwest Research institute
Test material
- Reference substance name:
- Bis(2-ethylhexyl) adipate
- EC Number:
- 203-090-1
- EC Name:
- Bis(2-ethylhexyl) adipate
- Cas Number:
- 103-23-1
- Molecular formula:
- C22H42O4
- IUPAC Name:
- bis(2-ethylhexyl) adipate
- Test material form:
- liquid
Constituent 1
- Specific details on test material used for the study:
- - Name of test material (as cited in study report): DEHA
- Analytical purity: >99.7%
- Impurities (identity and concentrations): no data - Radiolabelling:
- yes
- Remarks:
- Radiolabeled material was prepared by NEN (Boston), and supplied through the CMA. Lot No. 1679-109, specific activity 32.2 mCi/mmol. Radiochemical purity 98.9% (TLC). HPLC analysis by MRI showed >97%.
Test animals
- Species:
- mouse
- Strain:
- B6C3F1
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Breeding Lab. (Wilmington, Massachusetts).
- Age at study initiation: 50-57 days
- Weight at study initiation: 14-24 gram
- Fasting period before study: 18 hours prior to dosing
- Individual metabolism cages: yes
- Diet: ad libitum
- Water :ad libitum
- Acclimatisaton period: at least 7 days
ENVIRONMENTAL CONDITIONS
- Temperature (°F): 68-72:
- Humidity (%): 40-60
- Air changes (per hr): 10-15
- Photoperiod (hrs dark / hrs light): 12/12
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on exposure:
- The mice were dosed orally with 14C-DEHA at the low, mid, or high dose (50, 500 and 5000 mg/kg).
- Duration and frequency of treatment / exposure:
- once
Doses / concentrationsopen allclose all
- Dose / conc.:
- 50 mg/kg bw/day
- Dose / conc.:
- 500 mg/kg bw/day
- Dose / conc.:
- 5 000 mg/kg bw/day
- No. of animals per sex per dose / concentration:
- hydrolysis and absorption: 6 animals per sex and dose group
hydrolysis and absorption repeat: 3 animals per sex and dose group
preliminary disposition (only males): 2 males per dose group
disposition: 4 animals per sex for the low and high dose group, 8 animals per sex for the high dose group - Control animals:
- no
- Positive control reference chemical:
- no data
- Details on study design:
- Three groups of four male and four female mice each were treated orally with the low, mid, or high dose levels of 14C-DEHA
(50, 500 and 5000 mg/kg) and were placed in individual glass metabolism cages (Delmar-Rath type).
Expired air, urine, and feces were collected during 0-6, 6-12, and 12-24 hr intervals following dosing.
The expired 14 C02 was trapped with 5-Methol-amine in 2-methoxyethanol. Other volatile products were collected in
methanol:water (50:50).
Urine was collected in containers kept on dry ice. After each collection, the cages were rinsed and the cage washings were measured
and analyzed.
At 24 hr, the mice were anesthesized with ether, blood was withdrawn by cardiac puncture, and the following tissues and organs were
removed, weighed, and assayed for 14-C content: Liver, Spleen, Urinary bladder, Kidneys, Adrenals, Skeletal muscle, Lungs, Testes ,
Retroperitoneal tissue, Brain, Epididymides, GI tract plus contents, Heart, Skin, pancreas, ovaries and uterus.
Portions of blood were centrifuged to separate plasma and red blood cells (RBC's). Bladder contents were removed and the bladder was
washed thoroughly with 0.9% saline. The contents and washings were combined with the final urine samples and analyzed.
Blood and tissues were kept on ice during the necropsy procedures. Sample preparatian and analyses were performed immediately after collection, or the samples were frozen until analyzed. The remaining tissue and excreta were stored frozen. - Details on dosing and sampling:
- PHARMACOKINETIC STUDY (Absorption, distribution, excretion)
- Tissues and body fluids sampled : Expired air, urine, and feces, cage washes, and:
blood, Liver, Spleen, Urinary bladder, Kidneys, Adrenals, Skeletal muscle, Lungs, Testes ,
Retroperitoneal tissue, Brain, Epididymides, GI tract plus contents, Heart, Skin, pancreas, and ovaries and uterus.
- Time and frequency of sampling: Expired air, urine, and feces and cage washings during 0-6, 6-12, and 12-24 hr intervals following dosing.
Other tissues at sacrifice after 24 hrs.
METABOLITE CHARACTERISATION STUDIES
- Tissues and body fluids sampled : urine, GI-content
- Time and frequency of sampling: 24 hrs
- From how many animals: samples pooled
- Method type(s) for identification: HPLC-MS-MS
- Statistics:
- The means ± standard errors were calculated for each test group with a programmable calculator. Data were subjected to analysis of variance.
Significant F-ratios were then analyzed by Dunnett's procedure. Significant differences were indicated when p < 0.05.
Results and discussion
- Preliminary studies:
- A preliminary study in males only:
Absorption
dose mg/kg: 50, 500, 5000
Urine +expired air : 81% 86% 67%
excretion (24 hr)
dose mg/kg: 50, 500, 5000
Urine +expired air+ feces : 94% 101% 75%
Toxicokinetic / pharmacokinetic studies
- Details on absorption:
- At 24 hr
dose mg/kg: 50, 500, 5000
Urine +expired air: 92-94% 98-100% 67- 76%
- Details on distribution in tissues:
- Levels in organs were low (< 0.3%) . From all tissues examined the liver and kidneys showed the highest level ( 0.1-0.2% and 0.03-0.086% resp.).
Also in the GI-tract the levels were relatively high, and highest in 5000 mg/kg group (12%).
- Details on excretion:
- At 24 hr
dose mg/kg: 50, 500, 5000
Urine +expired air+ feces : 97-98% 98-100% 69-81%
Metabolite characterisation studies
- Metabolites identified:
- yes
- Details on metabolites:
- The GI tract contained the diester, monoester, and the alcohol, and traces of the polar material.
The liver contained primarily the oxidation products.
The urine contained major amounts of the oxidation products and their conjugated derivatives. Although the liver
profiles did not contain appreciable amounts of the less polar metabolites, these products may have been excreted shortly following formation.
Metabolites identified:
MEHA : monoethylhexyladipate
EH: ethylhexanol and EH glucuronide
EHA: ethylhexanoic acid, and EHA glucuronide
DiEHA: ethylhexanedioic acid
Any other information on results incl. tables
Hydrolysis and Absorption: 14C-DEHA and/or its metabolites was rapidly absorbed from the GI tract. The highest 14C levels were found in blood and liver 1 or 3 hr after dosing. In the GI tracts large amounts of the diester (DEHA) , monoester(MEHA)and alcohol (EH) were found. The quantities of DEHA decreased with time while other products increased. The major metabolites in the livers were more polar than EH. In general, only small amounts of DEHA, MEHA and EH were found. The livers of male mice also contained large amounts of an early eluting metabolite which was found in female livers in only small quantities. The extent of the two major metabolites recovered in livers of female mice differed significantly.
Disposition:
Preliminary studies with males: after treatment with 50 and 500mg/kg 14C-DEHA, 95-102% was eliminated in urine, feces and expired air within 24 hr. After 5,000 mg/kg, most of the 14C was excreted in 24 hr but ~12% were also recovered in the GI tracts.
Definitive studies with male and female mice (50, 500 and 5,000 mg/kg 14C-DEHA): urinary elimination of 14C was rapid and extensive. About 91% of the low and mid doses were eliminated in urine in 24 hr; only 75% after 5,000 mg/kg. Elimination in feces was 7-8% at the low and mid doses and 4% at the high dose. The latter group showed high recovery in the GI tract. Only 0.8 to 1.2% in males and 1.5 to 3.8% in females were eliminated in the expired air. Respiratory elimination was highest in the female low dose group. Only small amounts were found in blood and tissue 24 and 48 hr after dosing. Adrenals and livers showed the highest levels at low and mid dose, especially in males. After 5,000 mg/kg, blood also contained high 14C levels; blood and liver content of the females were significantly higher than of males. At 48 hr, the skin (both sexes) and the fat (females) showed higher retention of 14C than other tissues.
The high recovery in the GI tract following the high dose (12%) may account for the lower elimination in feces.
Applicant's summary and conclusion
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.